相关实验视频

Updated: Sep 18, 2025

Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation

Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation

Published on: September 20, 2017

BIRC5的上调增强了DNMT3A突变T-ALL细胞的存活率和病变发生

Wangisa Dunuwille¹, William C Wilson¹, Hassan Bjeije¹

¹Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO.

Blood neoplasia

|June 24, 2025

概括

在DNMT3A突变驱动成年T细胞急性淋巴细胞白血病 (T-ALL) 耐化疗. 准JAK/STAT信号或BIRC5 (含有5重复的Baculoviral IAP) 可以恢复敏感性并消除T-ALL细胞.

科学领域:

血液学血液学血液学
在瘤学瘤学.
分子生物学分子生物学

背景情况:

T细胞急性淋巴细胞白血病 (T-ALL) 是一种严重的血液癌症.
成人T-ALL结局落后于儿科病例,需要新的治疗策略.
DNMT3A突变发生在10-18%的成年T-ALL患者中,与预后不佳相关.

研究的目的:

研究DNMT3A突变T-ALL耐药性背后的机制.
为了确定DNMT3A突变T-ALL.的潜在治疗点.

主要方法:

对具有或没有DNMT3A突变的初级人类T-ALL标本的分析.
对亡和化疗敏感性的评估.
对JAK/STAT信号通路活动的评估.
在体外和体内抑制了JAK/STAT和BIRC5 (含有5的巴库洛病毒IAP重复).
在体内研究中使用患者衍生的异种移植.

主要成果:

DNMT3A突变的T-ALL细胞表现出对亡和化疗的抗性.
升高的JAK/STAT信号促进了DNMT3A突变T-ALL.中的生存.
JAK/STAT抑制使细胞对化疗重新敏感.
在DNMT3A突变型T-ALL.ALL中,BIRC5 (含有Baculoviral IAP重复5的病毒) 的上调.
观察到对BIRC5抑制剂YM155的特定敏感性.
在体内对BIRC5的基因抑制导致DNMT3A突变T-ALL细胞的快速耗尽.

结论:

在T-ALL中,DNMT3A突变通过增强的JAK/STAT信号和BIRC5上调来赋予T-ALL的化学抵抗.
准BIRC5代表了对DNMT3A突变的成年T-ALL患者有前途的精准医学策略.

更多相关视频

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues

Published on: August 23, 2024

Assessing Somatic Hypermutation in Ramos B Cells after Overexpression or Knockdown of Specific Genes

Assessing Somatic Hypermutation in Ramos B Cells after Overexpression or Knockdown of Specific Genes

Published on: November 1, 2011

相关概念视频

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...